Geoffrey R. Oxnard, MD; Ruthia Chen, MD; Jennifer C. Pharr, MD; Diane R. Koeller, MS, MPH, CTGC; Arrien A. Bertram, BS; Suzanne E. Dahlberg, PhD; Irene Rainville, PhD, CGC; Kate Shane-Carson, LGC; Kelly A. Taylor, MS, LCGC, CCRIP; Alicia Sable-Hunt, RN, MBA, CCRA, ACRP-PM; Lynette M. Sholl, MD; Craig C. Teerlink, PhD; Alun Thomas, PhD; Lisa A. Cannon-Albright, PhD; Andre P. Fay, MD; Patricia Ashton-Prolla, MD, PhD; Hao Yang, MS; Mary M. Salvatore, MD; Bonnie J. Addario; Pasi A. Janne, MD, PhD; David P. Carbone, MD, PhD; Georgie L. Wiesner, MD, MS; and Judy E. Garber, MD, MPH. Germline EGFR Mutations and Familial Lung Cancer. Journal of Clinical Oncology, October 23, 2023, DOI: 10.1200/JCO.23.01372
Barbara J. Gitlitz, MD, Silvia Novello, MD, PhD, Tiziana Vavala, MD, Marisa Bittoni, PhD, Alicia Sable-Hunt, RN MBA, Dean Pavlick, BS, Robert Hsu, MD, S. Lani Park, PhD, MPH, Ruthia Chen, BA, Matthew Cooke, BA, Amy Moore, PhD, Alexa B. Schrock, PhD, Joan H. Schiller, MD, Bonnie J. Addario, Geoffrey R. Oxnard, MD. The Genomics of Young Lung Cancer: Comprehensive Tissue Genomic Analysis in Patients Under 40 With Lung Cancer. JTO Clinical And Research Reports July 01, 2021, Volume 2, Issue 7, 100194.
Marissa N. Lawrence, BS, Rubii M. Tamen, BA, Pablo Martinez, MD, PhD, Alicia Sable-Hunt, RN, MBA, CCRA, Tony Addario, Pete Barbour, MS, MPM, PMP, Tristan Shaffer, BS, Seyed Ali Hosseini, MD, PhD, Caterina Bertucci, BS, MPA, Lee P. Lim, PhD, Fangxin Hong, PhD, Kesi Michael, BS, George R. Simon, MD, Jonathan W. Riess, MD, PhD, Mark M. Awad, MD, PhD, Geoffrey R. Oxnard, MD. SPACEWALK: A Remote Participation Study of ALK Resistance Leveraging Plasma Cell-Free DNA Genotyping. JTO Clinical and Research Reports Aporil 01, 2021, Volume 2, Issue 4, 100151.
B. Gitlitz, S. L. Parks, M. Bittoni, A. Sable-Hunt, A. Moore, D. Pavlick, S. Novello, T. Vavala, R. Chen, G. Oxnard, Genetech, South San Francisco/ USA, Keck School of Medicine of USC, Los Angeles/ USA, Ohio State University, Columbus/ USA, GO2 Foundation for Lung Cancer, San Carlos/ USA, Addario Lung Cancer Medical Institute, Foundation Medicine, Cambridge/ USA, AOU San Luigi, University of Turin/ Italy, SC of Oncology Ospedale Civile di Saluzzo, ASL CN1, Saluzzo/ Italy, Dana-Farber Cancer Institute, Boston/ USA. P1.14 - Targeted Therapy. Posted Viewing in the Exhibit Hall, World Lung Poster, September 2019.
Barbara Gitlitz, Alicia Sable-Hunt, Steven Young, Andreas Kogelnik, Danielle Hicks, Deborah Morosini, Tiziana Vavala, Marisa Bittoni, S. Lani Park, Silvia Novello, Geoffrey Oxnard, Bonnie Addario. P3.06-008 Employing Remote Web Consenting and Social Media to Facilitate Enrollment to an International Trial on Young Lung Cancer. Journal of Thoracic Oncology. January 2017, volume 12, Issue 1, Supplement, Pages S1428-S1429.
Barbara J. Gitlitz, Deborah Morosini, Alicia L. Sable-Hunt, Bonnie J. Addario, Stacy L. Mach, Mark Byron Jennings, S. Lani Park, Marisa A Bittoni, Geoffrey R. Oxnard. The Genomics of Young Lung Cancer Study. ASCO Poster, 2016.
Barbara J. Gitlitz, Deborah Morosini, Alicia L. Sable-Hunt, Bonnie J. Addario, Mark Byron Jennings, Stacy L. Mach, Geoffrey R. Oxnard. The genomics of Young Lung Cancer Study. 2015 American Society of Clinical Oncology, Annual Meeting May 29-June 2, 2015. J Clin Oncol 33, 2015 (suppl; abstr TPS11110)
Barbara J. Gitliz, Deborah Morosini, Alicia Sable-Hunt, Bonnie J Addario, Geoffrey R. Oxnard. The Genomics of Young Lung Cancer Study. American Associated for Cancer Research. Translation of the Cancer Genome, San Francisco, California, February 2015
Geoffrey R. Oxnard, Jennifer C. Heng, Elizabeth J. Root, Irene R. Rainville, Alicia L. Sable-Hunt, Kate P Shane-Carson, David Paul Carbone, Georgia L. Wiesner, Judy Ellen Garber. Initial results of a prospective, multicenter trial to study inherited lung cancer risk associated with germline EGFR T790M: INHERIT EGFR. ASCO Poster, 2015.
Gitlitz, B.J., Morosini, D., Sable-Hunt, A.L., Addario, B.J., Oxnard, G.R. The Genomics of Young Lung Cancer Study. ASCO Poster, 2015.
Oxnard, G.R., Heng, J., Rainville, I., Root, E., Dahlberg, S.E., Sable-Hunt, A.L., Wiesner, G.L., Taylor, K.A., Jackman, D.M., Janne, P.A., Garber, J.E. The INHERIT EGFR study: Investigating Hereditary Risk from T790M. AACR Poster, 2013.
Oxnard, G.R., Heng, J., Rainville, I., Root, E., Dahlberg, S.E., Sable-Hunt, A.L., Wiesner, G.L., Taylor, K.A., Jackman, D.M., Janne, P.A., Garber, J.E. The INHERIT EGFR study: Investigating Hereditary Risk from T790M. ASCO Poster, 2013.
Sable-Hunt, A. (2013). Clinical Trials. In Bonnie J. Addario Lung Cancer Foundation Navigating Lung Cancer 360 of Hope. San Carlos, CA.
Sable-Hunt, A. (2010). Sable’s Foods – The Cancer Nutrition Challenge. In Weight Loss EMPOWERMENT (pp. 231, 232). Rancho Santa Margarita, CA: Grande Gringos, Inc.
Ahmann, G., Chng, WJ., Henderson, K., Price-Troska, TL., DeGoey, RW., Timm, MM., Dispenzieri, A., Greipp, PR., Sable-Hunt, A., Bergsagel, L., Fonseca, R. Impact of Tissue Shipping on Plasma Cell Isolation, Viability, and RNA Integrity in the Context of a Centralized Good Laboratory Practice Certified Tissue Banking Facility. AACR 2008.
Stewart, AK, Chang, H., Trudel, S., Anderson, KC, Richardson, P., Alsina, M., Reece, D., Young, S., Sable-Hunt, A., Li, Z., Keats, J., Van Wier, S., Ahmann, G., Price-Troska, T., Giusti, K., Bergsagel, PL, Chesi, M., Fonseca, R. (2007). Diagnostic evaluation of t(4;14) in multiple myeloma and evidence for clonal evolution. Leukemia, 21(11): 10.1038. NIHMSID: NIHMS181755. PMCID: PMC3882151
Stewart, K., Tudel, S., Chang, H., Anderson, K., Richardson, P., Alsina, M., Reece, D.E., Greipp, P., Young, S., Sable-Hunt, A., Li, Z.H., Keats, J., Van Wier, S., Ahmann, G., Price-Troska, T., Giusti, K., Fonseca, R. Diagnostic Evaluation of t[4;14] in Multiple Myeloma. ASH Poster, December 2006.
Sable-Hunt, A. (2006). Case study: Multiple Myeloma Research Consortium. LabVantage Solutions.
R. C. Frank, A. Coscia, L. Versea, N. Cohen, R. Zelkowitz, A. Ruskin, A. Skeris (Sable-Hunt), P. Dodds and K. Nair. Low dose docetaxel, estramustine and thalidomide followed by maintenance thalidomide for the treatment of hormone refractory prostate cancer (HRPC): A phase II community based trial. J Clin Oncol (Meeting Abstracts) July 2004 vol. 22 no. 14_suppl 4681.